/CSL
CSL
Updated 12 Oct 06:33 am
$184.81
CSL LIMITED
1D+0.53%
1M+10.60%
1Y-10.33%
Track your position in CSL
Sign in to TradeLedgr to record trades in CSL (CSL LIMITED) with broker-true precision and ATO-compliant reporting.
Recent Announcements
08 Oct 2026 7:44 AM
Update on U.S. Plasma Collection Network123KB
Progress Report
06 Oct 2026 10:24 PM
CSL prices US$1.5 billion in Corporate Bonds186KB
Issued Capital - Other
04 Oct 2026 9:22 PM
CSL enters exclusive agreement with Alentis Therapeutics131KB
Progress Report
23 Sep 2026 10:22 PM
Update - Notification of buy-back - CSL11KB
Daily Share Buy-Back Notice
22 Sep 2026 10:17 PM
Update - Notification of buy-back - CSL11KB
Daily Share Buy-Back Notice
Fundamentals
P/E Ratio
—
Div Yield
220.50%
EPS
$-7.7332
Avg Vol
—
52W High
$222.470
52W Low
$90.000
Company Profile
Development, manufacturing and marketing of pharmaceutical and diagnostic products, cell culture media and human plasma fractions.
Financial History
2026A
$-2579.0M profit
$15797.0M rev
2025A
$3002.0M profit
$15558.0M rev
2024A
$2642.0M profit
$14800.0M rev